Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.

Gao L, Cheng HY, Dong L, Ye X, Liu YN, Chang XH, Cheng YX, Chen J, Ma RQ, Cui H.

J Int Med Res. 2011;39(5):1645-60.

PMID:
22117965
2.

Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer.

Zou SL, Chang XH, Ye X, Cheng HY, Cheng YX, Tang ZJ, Zhang ZJ, Gao L, Chen XH, Cui H.

Chin Med J (Engl). 2011 Oct;124(19):3133-40.

3.

Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility.

Lu R, Sun X, Xiao R, Zhou L, Gao X, Guo L.

Biochem Biophys Res Commun. 2012 Mar 9;419(2):274-80. doi: 10.1016/j.bbrc.2012.02.008.

PMID:
22342977
4.

[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].

Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H.

Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):931-6. Chinese.

PMID:
19134334
5.

Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients.

Steffensen KD, Waldstrøm M, Brandslund I, Jakobsen A.

Int J Gynecol Cancer. 2011 Aug;21(6):1040-7. doi: 10.1097/IGC.0b013e31821e052e.

PMID:
21738039
6.

Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.

Paek J, Lee SH, Yim GW, Lee M, Kim YJ, Nam EJ, Kim SW, Kim YT.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):338-42. doi: 10.1016/j.ejogrb.2011.05.021.

PMID:
21683503
7.

Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer.

Hynninen J, Auranen A, Dean K, Lavonius M, Carpen O, Perheentupa A, Seppänen M, Grénman S.

Int J Gynecol Cancer. 2011 Dec;21(9):1573-8. doi: 10.1097/IGC.0b013e3182225509.

PMID:
21811175
8.

Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.

Kong X, Chang X, Cheng H, Ma R, Ye X, Cui H.

Int J Gynecol Cancer. 2014 Mar;24(3):427-36. doi: 10.1097/IGC.0000000000000078.

PMID:
24557433
9.

LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.

He Y, Wu X, Liu X, Yan G, Xu C.

J Proteome Res. 2010 Dec 3;9(12):6180-90. doi: 10.1021/pr100822v.

PMID:
21028892
10.

Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma.

Chang X, Ye X, Dong L, Cheng H, Cheng Y, Zhu L, Liao Q, Zhao Y, Tian L, Fu T, Chen J, Cui H.

Int J Gynecol Cancer. 2011 Jul;21(5):852-8. doi: 10.1097/IGC.0b013e31821a3726.

PMID:
21633297
11.

Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.

Zhang S, Lin QD, DI W.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):522-31.

PMID:
16681721
12.

[Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].

Jiang J, Xia M, Feng JB, Kong BH.

Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):398-402. Chinese.

PMID:
17697602
14.

Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.

Zhu L, Zhuang H, Wang H, Tan M, Schwab CL, Deng L, Gao J, Hao Y, Li X, Gao S, Liu J, Lin B.

Oncotarget. 2016 Jan 5;7(1):729-44. doi: 10.18632/oncotarget.6327.

15.

Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.

Wu L, Dai ZY, Qian YH, Shi Y, Liu FJ, Yang C.

Int J Gynecol Cancer. 2012 Sep;22(7):1106-12. doi: 10.1097/IGC.0b013e318263efa2. Review.

PMID:
22854652
16.

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.

Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A.

Br J Cancer. 2009 Apr 21;100(8):1315-9. doi: 10.1038/sj.bjc.6605011.

17.
18.

Metformin inhibits the development and metastasis of ovarian cancer.

Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H, La D, Hambly BD, Bao S, Di W.

Oncol Rep. 2012 Sep;28(3):903-8. doi: 10.3892/or.2012.1890.

PMID:
22752027
19.

Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.

Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z.

Mol Cancer Res. 2008 Jun;6(6):917-28. doi: 10.1158/1541-7786.MCR-08-0093.

20.

Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.

Lin J, Qin J, Sangvatanakul V.

Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):81-5. doi: 10.1016/j.ejogrb.2012.10.036. Review.

PMID:
23228410
Items per page

Supplemental Content

Support Center